title: Pituitary hormone dysfunction after proton beam radiation therapy in children with brain tumors.
abstract: OBJECTIVE
  To characterize endocrine dysfunction in pediatric patients with brain tumors who received proton beam (PB) radiation therapy and to compare those treated with PB radiotherapy only versus combined conventional and PB irradiation.
  
  
  METHODS
  A retrospective review of medical records of patients ≤18 years of age who received PB radiation therapy for a brain tumor between 2000 and 2008 was performed. Variables analyzed included patient demographics, tumor type, therapeutic modalities, radiation doses, and types and timing of endocrine dysfunction.
  
  
  RESULTS
  Thirty-eight patients were identified, of whom 31 (19 boys and 12 girls; mean age, 11.9 ± 3.3 years) had undergone endocrine evaluation. Of these patients, 19 received PB radiotherapy only and 12 received conventional plus PB irradiation. Before irradiation, a cranial surgical procedure was performed in 28 study subjects, and 22 received chemotherapy. The mean duration of follow-up after radiation therapy was 1.8 ± 0.8 years. Nine patients (47%) in the PB only group and 4 (33%) in the conventional plus PB group developed endocrine dysfunction (no significant difference) after cranial irradiation. Children with endocrine sequelae treated with PB irradiation alone received fewer cobalt gray equivalents than those treated with conventional plus PB irradiation (5,384 ± 268 versus 5,775 ± 226, respectively; P<.02), and pituitary hormone deficiencies were detected later during follow-up in those who received PB radiotherapy only versus conventional plus PB irradiation (1.17 ± 0.4 years versus 0.33 ± 0.11 year, respectively; P<.01).
  
  
  CONCLUSIONS
  A high rate of endocrine sequelae was seen in our study. Children with brain tumors treated with conventional plus PB irradiation developed endocrine dysfunction faster and received a higher radiation dose than those receiving PB radiotherapy only. Prior surgical treatment and chemotherapy were additional risk factors. Large prospective studies are needed to evaluate further the incidence of endocrine sequelae after PB irradiation in children.
authors: Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA. vids722@gmail.com
authors: Vidhya
authors: V
authors: Viswanathan
authors: Kamnesh R
authors: KR
authors: Pradhan
authors: Erica A
authors: EA
authors: Eugster
references: Pituitary. 2005;8(3-4):203-11
references: 16508716
references: Nat Clin Pract Oncol. 2004 Dec;1(2):97-103; quiz 1 p following 111
references: 16264827
references: Cancer J. 2009 Jul-Aug;15(4):298-305
references: 19672146
references: Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):121-9
references: 20452141
references: Nat Clin Pract Endocrinol Metab. 2009 Feb;5(2):88-99
references: 19165221
references: Cancer. 2008 Nov 1;113(9):2575-96
references: 18837040
references: Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):407-21
references: 12023146
references: J Pediatr Endocrinol Metab. 2004 Jan;17(1):55-66
references: 14960022
references: Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):979-86
references: 18325681
references: J Pediatr. 1991 Feb;118(2):226-8
references: 1993949
references: Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):45-50
references: 12182973
references: Endocrinol Metab Clin North Am. 2005 Sep;34(3):769-89, xi
references: 16085170
references: Endocr Relat Cancer. 2004 Dec;11(4):589-602
references: 15613441
references: N Engl J Med. 1993 Jan 14;328(2):87-94
references: 8416438
references: J Clin Endocrinol Metab. 2003 Jan;88(1):136-40
references: 12519842
references: Int J Cancer. 2008 Apr 15;122(8):1868-72
references: 18076068
references: J Clin Endocrinol Metab. 2003 Jul;88(7):3149-54
references: 12843158
references: Pediatr Blood Cancer. 2006 Feb;46(2):258-61
references: 16369923
references: Clin Oncol (R Coll Radiol). 2003 Feb;15(1):S37-50
references: 12602563